Copy to clipboard 
Demetra, provider of anti-infective cements, spacers and biomaterials for orthopedic applications, acquired a 51% stake in GetSet Surgical, a Swiss-based spine surgical solutions provider.
This investment will integrate the strengths of both companies, establishing a new approach to spine and orthopedic procedures. The use of sterile-packaged disposable implants and instruments helps to reduce the risk of infections and hospital costs associated with central sterilization issues, aligning directly with Demetra’s mission of becoming the company of choice for infection management and efficiency through its portfolio companies: Tecres, OSARTIS, OsteoRemedies and Yijiutai.
As part of its expansion plans, Demetra is prioritizing the introduction of GetSet’s products into the United States. The newly-established U.S. Spine Division of Demetra’s portfolio company OsteoRemedies will manage the distribution of these products. This division will be headed by Ted Bird, an industry veteran recently appointed Vice President Spine Commercial.
The initial U.S. product offerings will include GetSet’s GoPLF! Posterior Lateral Fusion system, already FDA cleared. Introduction of GetSet’s GoLIF! Lumbar Interbody Fusion system is anticipated to take place later this year following FDA 510(k) clearance, which is pending. Additional systems already in development will be expedited by this new investment.
Beyond the U.S., Demetra is committed to expanding GetSet Surgical’s products across its global operations. Both GoPLF! and GoLIF! are already CE-Marked and available for distribution in European and other international markets.
Source: Demetra Holding SpA
Demetra, provider of anti-infective cements, spacers and biomaterials for orthopedic applications, acquired a 51% stake in GetSet Surgical, a Swiss-based spine surgical solutions provider.
This investment will integrate the strengths of both companies, establishing a new approach to spine and orthopedic procedures. The use of sterile-packaged...
Demetra, provider of anti-infective cements, spacers and biomaterials for orthopedic applications, acquired a 51% stake in GetSet Surgical, a Swiss-based spine surgical solutions provider.
This investment will integrate the strengths of both companies, establishing a new approach to spine and orthopedic procedures. The use of sterile-packaged disposable implants and instruments helps to reduce the risk of infections and hospital costs associated with central sterilization issues, aligning directly with Demetra’s mission of becoming the company of choice for infection management and efficiency through its portfolio companies: Tecres, OSARTIS, OsteoRemedies and Yijiutai.
As part of its expansion plans, Demetra is prioritizing the introduction of GetSet’s products into the United States. The newly-established U.S. Spine Division of Demetra’s portfolio company OsteoRemedies will manage the distribution of these products. This division will be headed by Ted Bird, an industry veteran recently appointed Vice President Spine Commercial.
The initial U.S. product offerings will include GetSet’s GoPLF! Posterior Lateral Fusion system, already FDA cleared. Introduction of GetSet’s GoLIF! Lumbar Interbody Fusion system is anticipated to take place later this year following FDA 510(k) clearance, which is pending. Additional systems already in development will be expedited by this new investment.
Beyond the U.S., Demetra is committed to expanding GetSet Surgical’s products across its global operations. Both GoPLF! and GoLIF! are already CE-Marked and available for distribution in European and other international markets.
Source: Demetra Holding SpA
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
